India’s Precision Medicine: A Vision Hindered by Biobank Regulations
Precision medicine, a transformative approach to healthcare, is redefining the landscape of disease diagnosis and treatment. From groundbreaking personalised healthcare solutions to innovations like mRNA vaccines and gene-editing technologies, the field promises a new era in medical science. Yet, as India stands on the cusp of this revolution, a significant hurdle looms: the lack of robust biobank regulations.
Biobanks, essential repositories of biological samples, are critical to the success of precision medicine. These collections of blood, DNA, and tissue samples, coupled with genetic data, form the backbone of research aimed at developing targeted therapies for diseases like cancer and diabetes. However, as highlighted in a recent analysis by The Hindu, India’s inconsistent biobank regulations threaten public trust and impede progress.
The Promise of Precision Medicine
In recent years, precision medicine has witnessed remarkable achievements. Through gene therapy, researchers have restored vision in individuals with genetic mutations, while in the U.K., scientists have reversed diabetes using reengineered stem cells. The rapid development of COVID-19 vaccines using the mRNA platform, which earned a Nobel Prize, further underscores the potential of precision medicine.
India’s Growing Market
The Indian precision medicine market is burgeoning, with projections estimating a value exceeding $5 billion by 2030. Initiatives like the BioE3 policy and the approval of NexCAR19, a domestically developed CAR-T cell therapy, mark significant strides. However, the true potential of these advancements lies in aligning biobank regulations with international standards.
The Biobank Conundrum
While countries like the U.K., U.S., and Japan have comprehensive biobank regulations ensuring data protection and privacy, India’s framework remains fragmented. The absence of a single authority to regulate biobanks and the lack of penalties for misconduct create risks of ethical violations and undermine public confidence. As the ICMR guidelines illustrate, participants often consent to provide samples without clarity on data usage, raising concerns about privacy and potential discrimination.
A Path Forward
To harness the full potential of precision medicine, India must establish stringent biobank regulations. Aligning with global standards will not only bolster public trust but also position India as a leader in next-generation therapeutics. As part of international groups like the Quad and BRICS, India has the opportunity to expand its pharmaceutical leadership and enhance its soft diplomatic efforts.
Manjeera Gowravaram, a PhD in RNA biochemistry, provides insightful analysis on the intersection of science and policy.
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
Commercial real estate is entering its most transformative era yet. In 2026, success hinges on mastering predictive analytics, smart‑building automation, and sustainability tech—tools that now determine everything from ROI forecasting to tenant retention. As PropTech evolves into an interconnected ecosystem of AI, automation, and ESG‑driven systems, CRE professionals who embrace this shift will lead the next generation of market innovation, while those who rely on traditional instincts risk being left behind.
Florida lawmakers are pushing major reforms that could dramatically change life for more than 800,000 mobile home park residents. New bills would force park owners to justify rent increases, expand relocation assistance, strengthen tenant rights, and add penalties for reducing amenities without lowering rent. With many residents facing steep price jumps on fixed incomes, the proposed laws mark one of the state’s biggest moves toward accountability and transparency in decades — and real estate professionals will need to stay informed as the changes progress.
Refinance activity exploded for a second straight week as mortgage rates briefly dipped to their lowest levels since late 2024. Homeowners rushed to lock in savings, pushing refinance applications to nearly triple last year’s volume. But the momentum may be short‑lived. Early this week, rates spiked again as markets reacted to new tariff concerns and global uncertainty, erasing much of the recent progress. Both refinance and purchase demand remain strong, but volatility continues to challenge borrowers and professionals across the real estate and mortgage sectors.
The real estate industry has officially entered its AI era, with agents across the country adopting advanced tools that streamline workflow, boost productivity, and transform daily operations. According to a new HousingWire report, tasks that once took hours now take minutes, agents are seeing up to 40 percent productivity growth, and unified AI platforms are helping brokerages deliver faster, smarter, and more personalized marketing than ever before.
Hawai‘i enters 2026 with a mix of strength and vulnerability. Construction is booming with billions in federal and military projects, yet tourism—the backbone of the local economy—is slowing at a difficult moment. Real estate shows early signs of revival as mortgage rates fall, while health care, small business, and banking navigate shifting federal funding and economic uncertainty. For professionals across real estate, finance, construction, and other licensed industries, Hawai‘i offers a clear preview of the economic pressures and emerging opportunities taking shape nationwide.
Florida’s property insurance market is stabilizing after years of turmoil, but lawmakers say the job isn’t done. New proposals target profit‑sharing oversight, premium transparency, and a statewide claim‑free discount program—offering potential relief for homeowners and key insights for real estate and mortgage professionals navigating the shifting landscape.
Biobanks, essential repositories of biological samples, are critical to the success of precision medicine. These collections of blood, DNA, and tissue samples, coupled with genetic data, form the backbone of research aimed at developing targeted therapies for diseases like cancer and diabetes. However, as highlighted in a recent 
While countries like the U.K., U.S., and Japan have comprehensive biobank regulations ensuring data protection and privacy, India’s framework remains fragmented. The absence of a single authority to regulate biobanks and the lack of penalties for misconduct create risks of ethical violations and undermine public confidence. As the 
